Development and evaluation of antimicrobial and modulatory activity of inclusion complex of euterpe oleracea mart oil and β-cyclodextrin or HP-β-cyclodextrin by de Almeida Magalhaes, T. S. S. et al.
 International Journal of 
Molecular Sciences
Article
Development and Evaluation of Antimicrobial and
Modulatory Activity of Inclusion Complex of
Euterpe oleracea Mart Oil and β-Cyclodextrin or
HP-β-Cyclodextrin
Thalita Sévia Soares de Almeida Magalhães 1 , Pollyana Cristina de Oliveira Macedo 1,
Stephany Yumi Kawashima Pacheco 1, Sofia Santos da Silva 2, Euzébio Guimarães Barbosa 2,
Rayanne Rocha Pereira 3, Roseane Maria Ribeiro Costa 3, José Otávio Carréra Silva Junior 3 ,
Marília Andreza da Silva Ferreira 4, José Cezário de Almeida 4, Pedro José Rolim Neto 5,
Attilio Converti 6 and Ádley Antonini Neves de Lima 1,*
1 Department of Pharmacy, Laboratório Escola de Farmácia Industrial, Federal University of Rio Grande do
Norte, Natal, RN 59012-570, Brazil; thalitasevia22@gmail.com (T.S.S.d.A.M.);
macedopollyanax@gmail.com (P.C.d.O.M.); teh.pacheco@hotmail.com (S.Y.K.P.)
2 Department of Pharmacy, Laboratório de Química Farmacêutica Computacional, Federal University of Rio
Grande do Norte, Natal, RN 59012-570, Brazil; sofiassilvam@hotmail.com (S.S.d.S.);
euzebiogb@gmail.com (E.G.B.)
3 Department of Pharmacy, Laboratório de Pesquisa e Desenvolvimento Farmacêutico e Cosmético, Federal
University of Pará, Pará, PA 66075110, Brazil; rayannerocha548@gmail.com (R.R.P.);
roseribeiro01@yahoo.com.br (R.M.R.C.); carrera@ufpa.br (J.O.C.S.J.)
4 Department of Nursing, Laboratorio de Microbiologia, Parasitologia and Patologia, Federal University of
Campina Grande, Paraíba, PB 58900000, Brazil; marilia.andreza.masf@gmail.com (M.A.d.S.F.);
cezarioja@gmail.com (J.C.d.A.)
5 Department of Pharmacy, Laboratory of Medical Technology, Federal University of Pernambuco, Recife,
PE 50740-521, Brazil; rolim.pedro@gmail.com
6 Dipartimento of Civil, Chemical and Environmental Engineering, Pole of Chemical Engineering, Genoa
University, I-16145 Genoa, Italy; converti@unige.it
* Correspondence: adleyantonini@yahoo.com.br; Tel.: +55-(84)-99928-8864
Received: 21 November 2019; Accepted: 9 January 2020; Published: 31 January 2020


Abstract: The development of inclusion complexes is used to encapsulate nonpolar compounds
and improve their physicochemical characteristics. This study aims to develop complexes made
up of Euterpe oleracea Mart oil (EOO) and β-cyclodextrin (β-CD) or hydroxypropyl-β-cyclodextrin
(HP-β-CD) by either kneading (KND) or slurry (SL). Complexes were analyzed by molecular
modeling, Fourier-transform infrared spectroscopy, scanning electron microscopy, powder X-ray
diffraction, thermogravimetry analysis and differential scanning calorimetry. The antibacterial
activity was expressed as Minimum Inhibitory Concentration (MIC), and the antibiotic resistance
modulatory activity as subinhibitory concentration (MIC/8) against Escherichia coli, Streptomyces aureus,
Pseudomonas aeruginosa and Enterococcus faecalis. Inclusion complexes with β-CD and HP-β-CD were
confirmed, and efficiency was proven by an interaction energy between oleic acid and β-CD of
−41.28 ± 0.57 kJ/mol. MIC values revealed higher antibacterial activity of complexes compared to
the isolated oil. The modulatory response of EOO and EOO-β-CD prepared by KND as well as of
EOO-β-CD and EOO-HP-β-CD prepared by SL showed a synergistic effect with ampicillin against
E. coli, whereas it was not significant with the other drugs tested, maintaining the biological response
of antibiotics. The antimicrobial response exhibited by the complexes is of great significance because
it subsidizes studies for the development of new pharmaceutical forms.
Int. J. Mol. Sci. 2020, 21, 942; doi:10.3390/ijms21030942 www.mdpi.com/journal/ijms
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1. Introduction
Vegetable oils are a target of studies due to their many pharmacological applications. According
to Martins da Silva et al. [1], the chemical constituents present in a variety of oils exhibit different
biological activities. The resin oil of Copaifera multijuga, commonly used as an anti-inflammatory [2],
the essential oil of Ocimum basilicum, applied as an antihyperalgesic [3], and the Allium sativum oil,
displaying antioxidant and antimicrobial activities [4] similar to those of Euterpe oleracea oil [5,6], are a
few examples.
E. oleracea Mart oil (EOO), popularly known as açai oil, is largely produced in Brazil. Rich in
long-chain unsaturated fatty acids, its major constituent is oleic acid [7,8], which according to Souza [9]
represents 54.32% of the lipidic fraction, followed by palmitic acid (30%), linoleic acid (5.9%) and lower
concentrations of palmitoleic, vaccenic and stearic acids. Among the phytosteroids present in the
oil, the most important are β-sitosperol, stigmasterol and campesterol. Their ability to improve cell
metabolism and reduce inflammatory processes are the reasons why these compounds are widely used
by the cosmetic industry to prevent skin aging [10].
Recently, Marques et al. [11], who phytochemically characterized EOO, reported vanillic, palmitic,
γ-linolenic, linoleic, oleic, cinnamic, caffeic, protocatechuic, ferulic and syringic acids and the flavonoids
quercetin and kaempferol rutinoside as the main phytochemical components of the oil. This variety of
constituents may justify the biological activities of açai oil already described [12–15]. Different studies
have shown that EOO has antidiarrheal [16], anti-inflammatory and antinociceptive [8] actions, an
inhibitory effect against Staphylococcus aureus [6], antiproliferative action [17], and an antiatherogenic
effect [9]. The absence of cytotoxicity and genotoxicity was also described [11].
Despite the wide range of promising pharmacological properties, oils are poorly used by the
pharmaceutical industry due to their low solubility. To solve this problem, drugs may be complexed
with different compounds that are often able to improve their physicochemical properties. Among
these, cyclodextrins (CD) are the most frequently used [3,18] followed by polymers such as polyethylene
glycol, polyethylene oxide, polyvinyl alcohol and polyvinylpyrrolidone [19].
CD have been used as a pharmaceutical excipient able to increase the solubility of drugs. These
cyclic oligosaccharides also exhibit stable physicochemical characteristics capable of protecting host
molecules from degradation in the gastrointestinal tract and against oxidation, provide photo and
thermal stability, and reduce physiological effects, undesirable organoleptic characteristics, drug
volatility and toxicity [20–25].
In order to obtain oils with suitable physicochemical characteristics and to improve their functions
and pharmacological applications, formulations containing inclusion complexes are being developed,
where the product is chemically stable because its constituents are protected by reducing the exposure
to environmental and microbiological factors. In addition to these benefits, the formation of inclusion
complexes with EOO may improve their solubility, promote oxidative stability against photosensitivity
or temperature effects, and especially prevent hydrolytic rancidity.
This work aims to develop inclusion complexes of E. oleracea Mart oil with β-cyclodextrin
and hydroxypropyl-β-cyclodextrin prepared by kneading and slurry, in order to improve oil
physicochemical properties, solubility, stability and antimicrobial activity. The formation of inclusion
complexes and the interaction between oleic acid (the main oil component) and cyclodextrins was
investigated by Fourier-transform infrared spectroscopy, scanning electron microscopy, powder X-ray
diffraction, thermogravimetric analysis, and differential scanning calorimetry. The antibacterial and
modulatory activity of the inclusion complexes was tested against standard target bacterial strains
using the microdilution test.
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2. Results and Discussion
2.1. Chemical Characterization of Euterpe oleracea Mart Oil
The fatty acid profile determined using gas chromatography (Table 1) shows that the major EOO
constituents are oleic (47.58%), palmitic (24.06%) and linoleic (13.58%) acids, confirming the results
reported by Do Nascimento et al. [26], while palmitoleic (6.94%), myristic 14:0 (1.75%) and lauric
(4.77%) acids were detected in lower contents. This means that approximately 70% of fatty acids are
unsaturated, namely oleic acid (18:1), still classified as omega-9, linoleic acid (18:2), characterized as
an essential fatty acid capable of being metabolized into omega-6, and palmitoleic acid (16:1). The
presence of these compounds is consistent with the antiatherogenic power of this oil [9].
Table 1. Composition of Euterpe oleracea Mart oil fatty acids quantified using gas chromatography with
a flame ionization detector.
Fatty Acid Content in the Oil (%)
Oleic acid 18:1 47.58
Linoleic acid 18:2 13.58
Palmitic acid 16:0 24.06
Palmitoleic acid 16:1 6.94
Myristic acid 14:0 1.75
Lauric acid 12:0 4.77
2.2. Determination of the Interaction Energy
Apolar ligands of appropriate size tend to replace water molecules bound to cyclodextrin hydroxyl
groups in solution, forming more stable and less stressed systems called inclusion complexes [27–30].
To investigate the possible formation of such complexes between oleic acid, i.e., the major açai oil
component, and two different cyclodextrins, a molecular dynamic study was carried out by the Linear
Interaction Energy methodology. Figure 1 shows the positions at which the binder was positioned on
both cyclodextrins. The position of the binder within both cyclodextrins slightly interfered with the
scores obtained after the simulations, with the interaction energies (∆G) of the β-CD:oleic acid and
HP-β-CD:oleic acid systems being −41.28 ± 0.57 and 25.15 ± 0.44 kJ/mol, respectively.
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The formation of inclusion complexes is directly influenced by Van der Waals forces due to the 
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stable than the HP-β-CD:oleic acid ones. 
Figure 1. Schematic representation of the inclusion complexes of oleic acid with β-cyclodextrin (β-CD)
and hydroxy-propyl-β-cyclodextrin (HP-β-CD). (A) β-CD-oleic acid and (B) HP-β-CD-oleic acid, with
interaction energies of −41.28 ± 0.57 kJ/mol and 25.15 ± 0.44 kJ/mol, respectively. Images were obtained
using the UCSF-Chimera software [31].
The formation of inclusion complexes is directly influenced by Van der Waals forces due to the
lipophilic nature of cyclodextrin cavity [32]. Since β-CD chemical affinity for oleic acid is greater than
that of HP-β-CD, β-CD:oleic acid inclusion complexes are expected to form more easily and be more
stable than the HP-β-CD:oleic acid ones.
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Not all molecules in a compound form inclusion complexes, and EOO consists primarily of
fatty acids. According to Leclercq [33], β-CD are excellently suited to solubilize phospholipid and
easily include them in cyclodextrins, as they are also composed of fatty acids. This complexation,
which is characteristic of cyclodextrins, makes encapsulated compounds stable and improves the
physicochemical properties of the substance.
The formation of inclusion complexes is influenced by CD-linked substituents and, our findings
are in accordance with and Arima [34]. Hydrophilic substituents, such as 2-hydroxypropyl,
3-hydroxypropyl, and maltosil, for example, reduce hemolytic activity compared to original CDs,
while lipophilic substituents (e.g., methylated CDs) demonstrate stronger hemolytic activities [34].
This hemolysis is attributed to the complexation capacity of the CD and fatty acids and the removal of
this constituent from the erythrocyte membrane.
2.3. Physicochemical Characterization of Inclusion Complexes
2.3.1. Fourier Transform Infrared Spectroscopy (FT-IR)
Figure 2 depicts the FT-IR spectra of EOO,β-CD, HP-β-CD and the EOO-β-CD and EOO-HP-β-CD
inclusion complexes obtained by either kneading (KND) or slurry (SL). The EOO spectrum (Figure 2A)
showed relevant bands at wavenumbers of 2924-2849, 1745, 1458 and 1161 cm−1 that can be assigned
to C–H stretching vibrations, C=O stretching vibrations, C=C asymmetric deformation and C–O
stretching vibrations, respectively, while theβ-CD spectrum (Figure 2B) showed others at 3302, 1155 and
1024 cm−1, corresponding to O–H stretching vibrations, C–O asymmetric deformation and C–O–C
symmetric stretching vibrations, thereby confirming the results of Pinheiro et al. [2]. As expected, the
HP-β-CD spectrum (Figure 2E) exhibited the same characteristic bands detected for β-CD, besides the
additional band at 2918 cm−1 corresponding to C–H stretching vibrations, confirming the observations
by Medarevic´ et al. [35].
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Figure 2. FT-IR spectra of E. oleracea oil (EOO) (A), β-cyclodextrin (B), EOO-β-cyclodextrin
inclusion complexes prepared by kneading (C) and slurry (D), hydroxy-propyl-β-cyclodextrin (E), and
EOO-hydroxy-propyl-β-cyclodextrin inclusion complexes prepared by kneading (F) and slurry (G).
The spectrum of the EOO-β-CD inclusion complex prepared by KND (Figure 2C) showed the
typical O–H vibration band at 3319 cm−1 and an intensified C–O–C symmetric stretching vibrations
band at 1024 cm−1, which are characteristic of β-CD molecule, as well as reduced intensity or
even suppression of those characteristic of EOO. A similar behavior was observed for the same
inclusion complex prepared by SL (Figure 2D), with a reduction in the intensity of bands at 3330,
1155, 1024, 2924, 2855, 1745 and 1453 cm−1. EOO-HP-β-CD complexes prepared by both techniques
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exhibited qualitatively identical spectra, with the characteristic HP-β-CD bands at 3358 and 1018 cm−1
corresponding to O–H and C–O–C vibrations, respectively, while the EOO characteristic bands had
decreased intensity (Figure 2F,G).
Since this analytical technique detects the vibrational frequency of chemical bonds, the decreased
intensity and/or absence of EOO characteristic bands in the spectra of all preparations indicates an
interaction between oil and cyclodextrins that constitutes an indirect proof of inclusion complexes
formation [36]. Although no significant difference could be detected between spectra of inclusion
complexes prepared by kneading or slurry, the latter exhibited patterns more similar to those of their
respective cyclodextrins and less pronounced oil characteristic bands.
2.3.2. Scanning Electron Microscopy (SEM)
Figure 3 shows the micrographs of β-CD, HP-β-CD, EOO-β-CD and EOO-HP-β-CD. Both
EOO-β-CD complexes prepared by kneading (Figure 3C) and slurry (Figure 3E) displayed an amorphous
state, especially the former, with only very small differences between them. On the other hand, particle
appearance, shape and size were quite different between EOO-HP-β-CD complexes, in that, those
obtained by SL displayed an even larger difference than those obtained by KND compared to HP-β-CD.
As suggested by Bulani et al. [37], such modifications in particle shape and aspect may be taken as a
proof of the formation of inclusion complex with CD, thereby confirming the insights emerged from
FT-IR spectroscopy.
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Figure 3. SEM micrographs of β-cyclodextrin (A), hydroxy-propyl-β-cyclodextrin (B),
EOO-β-cyclodextrin inclusion complexes prepared by kneading (C) and slurry (E), and EOO-hydroxy-
propyl-β-cyclodextrin inclusion complexes prepared by kneading (D) and slurry (F). Images were
taken at a magnification of 100×.
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2.3.3. Powder X-ray Diffraction (PXRD)
Diffractograms of the same compounds and inclusion complexes are illustrated in Figure 4.
The β-CD crystalline profile is revealed by the presence of intense and narrow peaks, while HP-β-CD
displayed broad bands, which are characteristic of amorphous substances. The disappearance of
crystalline reflections and appearance of new reflections can be taken as a further confirmation of the
formation of inclusion complexes [38].
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Figure 4. Diffractograms of β-cyclodextrin (A), EOO-β-cyclodextrin inclusion complexes prepared
by kneading (B) and slurry (C), hydroxy-propyl-β-cyclodextrin (D), and EOO-hydroxy-propyl-β-
cyclodextrin inclusion complexes prepared by kneading (E) and slurry (F).
A comparison of the diffractogram of EOO-β-CD complex prepared by kneading (Figure 4B) with
that of β-CD (Figure 4A) points out the appearance of a peak at 6.67◦, the disappearance of β-CD peaks
at 8.98 and 10.60◦, a shift of the peak at 12.44 to 12.88◦, and a decrease in its intensity. Even though
the rofil of EOO-β-CD complex prepared by slurry (Figure 4C) was similar, the new peak appeared
at 6.78◦.
The HP-β-CD diffractogram (Figure 4D) is characterized by two wide bands, with the latter lying
at around 19◦ and being more evident, similarly as found by Medarevic´ et al. [34]. EOO-HP-β-CD
complexes prepared by either kneading (Figure 4E) or slurry (Figure 4F) exhibited a slight band
shrinkage and lengthening compared with HP-β-CD, but maintained its characteristic amorphous
structure, like that observed by SEM for complexes.
2.3.4. Thermogravimetry An lysis (TG/DTG)
The results of TG/DTG analysis are shown in Figure 5 and Table 2. EOO displayed a single mass
loss that can be associated with evaporation and/or pyrolysis of triglycerides. The event related to
mass loss occurred in the range of 200–400 ◦C with 95.01 % mass loss (Figure 5A,B). β-CD (Figure 5A)
exhibited mass losses of 13.60 and 69.18 % in the ranges of 40–200 and 200–400 ◦C, respectively, which
were likely associated with the release of surface ater molecules followed by degradation [39]. Curves
of EOO-β-CD complexes prepared by KND and SL showed at 40–200 ◦C mass losses of 7.19 and 7.39%
(Figure 5A), respectively, suggesting water loss from cyclodextrin since EOO did not lose mass in that
Int. J. Mol. Sci. 2020, 21, 942 7 of 18
range. The complex prepared by the latter method was also shown to be more resistant to degradation
at high temperatures (200–400 ◦C) (∆m = 58.97%).
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Table 2. Results of thermogravimetry analysis in terms of mass loss (%) in the temperature ranges
40–200, 200–400 and 400–600 ◦C.
Sample
∆m1 (%) ∆m2 (%) ∆m3 (%)
40–200 ◦C 200–400 ◦C 400–600 ◦C
EOO - 95.01 37.67
β-CD 13.60 69.18 10.88
EOO-β-CD (KND) 7.19 70.23 14.26
EOO-β-CD (SL) 7.39 58.97 11.37
HP-β-CD 4.60 82.46 9.09
EOO-HP-β-CD (KND) 5.45 74.01 10.01
EOO-HP-β-CD (SL) - 64.46 6.15
Abbreviations: EOO, Euterpe oleracea oil; EOO-β-CD, EOO and β-cyclodextrin inclusion complex; EOO-HP-β-CD,
EOO and hydroxy-propyl-β-cyclodextrin inclusion complex; KND, preparation by kneading; SL, preparation
by slurry.
The TG/DTG curve of HP-β-CD (Figure 5B) revealed 4.60% mass loss in the 40–200 ◦C range,
associated with the releas of water molecules from the surface of HP-β-CD, followed by sample
degradation with a loss f 82.46% in the range 2 –400 ◦C. Whereas the EOO-HP-β-CD complex
prepared by KND (Figure 5B) showed a 5.45% mass loss, that prepared by SL no mass loss at 40–200 ◦C
but higher mass loss at 200–400 ◦C (∆m = 74.00% and 64.46%, respectively), and EOO no mass loss at
40–200 ◦C. Thus, the formation of the EOO-β-CD and EOO-HP-β-CD complexes was evidenced for
both methodologies.
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2.3.5. Differential Scanning Calorimetry (DSC)
DSC curves of all preparations are illustrated in Figure 6. One can see the occurrence of three
endothermic events for EOO, the first involving a reaction enthalpy (∆H) of 0.04 J/g with onset
(Tonset) and peak (Tpeak) temperatures of 101.31 and 103.96 ◦C, respectively, the second ∆H = 0.14 J/g,
Tonset = 241.64 ◦C and Tpeak = 248.96 ◦C, and the third one ∆H = −0.02 J/g, Tonset = 285.40 ◦C and
Tpeak = 287.15 ◦C. The first two events did not show significant variations, while the third one suggests
evaporation and pyrolysis of fatty acids, corroborating with oil degradation with Tonset = 239.00 ◦C
and Endset = 444.76 ◦C. (Figure 5).
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β-CD exhibited an endothermic peak (Figure 6A) involving ∆H = 231.02 J/g with Tonset = 30.94 ◦C
and Tpeak = 73.71 ◦C, likely due to water release from its cavity, and a second event occurred at
Tonset = 223.50 ◦C (∆H = 0.75 J/g and Tpeak = 226.68 ◦C), similarly to the observations of Nascimento
et al. [3]. It was not possible to identify eventual endothermic events related to β-CD mass loss at
high temperatures [2,40] because a maximum temperature of 300 ◦C was set in this study. β-CD
complexes obtained by KND and SL showed similar behavior (Figure 6A) with Tonset = 27.07 ◦C
(∆H = 48.46 J/g and Tpeak = 42.72 ◦C) and 24.07 ◦C (∆H = 142.10 J/g and Tpeak = 48.86 ◦C), respectively,
both related to dehydration, but occurring at lower temperatures when compa ed to β-CD. Another
event characteri tic of β-CD stood out between 220 and 226 ◦C for complexes, whose intensity was
higher for that prepared by SL (∆H = 9.8 J/g) wh n compared to KND (∆H = 2.19 J/g). This difference
in enthalpy may have been related to the reduction of β-CD crystalline profile, especially in the case of
the latter complex; in addition, the characteristic peak of EOO at Tpeak = 248.96 ◦C disappeared in
these curves. Both results suggest the formation of inclusion complexes.
Similarly to what observed by Pinheiro et al. [2], HP-β-CD showed an endothermic peak (Figure 6B)
with Tonset = 37.25 ◦C (∆H = 6.47 J/g and Tpeak = 37.05 ◦C) related to water release from its surface,
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and a second event with Tonset = 240.39 ◦C (∆H = 1.98 J/g and Tpeak = 264.92 ◦C) related to the onset
of mass loss, starting at 241.89 ◦C on the TG curve (Figure 5B). HP-β-CD complexes obtained by KND
and SL behaved similarly (Figure 6B) with Tonset = 28.49 ◦C (∆H = 60.40 J/g and Tpeak = 68.32 ◦C) and
Tonset = 37.33 ◦C (∆H = 35.79 J/g and Tpeak = 101.53 ◦C), respectively, both related to dehydration.
Another event characteristic of HP-β-CD stood out between 234.35 and 249.41 ◦C, with no variation
in peak intensity attributable to the preparation method (∆H = 0.07 J/g). It was also observed in this
temperature range a characteristic peak of EOO at 248.47 ◦C (∆H = 0.14 J/g).
Bearing in mind that DSC is an important analytical tool for analyzing complexation between
drugs and cyclodextrins, any variation in peak temperature or intensity may be ascribed to the
formation of inclusion complexes [41]. Therefore, in agreement with the other analyses, the DSC results
confirm the formation of inclusion complexes by both cyclodextrins.
2.4. Minimum Inhibitory Concentration (MIC)
The rational use of antibiotics and the discovery of new drugs are pointed out as strategic actions
to avoid bacterial resistance [42,43]. For this purpose, the Minimum Inhibitory Concentrations (MIC)
of EOO, EOO-β-CD and EOO-HP-β-CD, which are indicative of their capability of preventing bacterial
activity, were visually determined by the microdilution method in wells.
It can be seen in Table 3 that the highest MIC values, which are associated with the lowest
bactericidal power, were obtained using EOO against Staphylococcus aureus (512 µg/mL), Enterococcus
faecalis (≥1024 µg/mL) and Escherichia coli (512 µg/mL), while both EOO-HP-β-CD complexes obtained
by KND and SL exhibited their highest efficacy against E. coli (MIC = 341 µg/mL) and the lowest
against Pseudomonas aeruginosa (MIC = 512 µg/mL). However, the best performance was obtained with
complexes prepared using β-CD as a carrier, especially the EOO-β-CD one obtained by SL, whose MIC
values against E. faecalis, P. aeruginosa, S. aureus, and E. coli were as low as 341, 384, 384, and 256 µg/mL,
respectively. Nonetheless, the EOO-β-CD complex prepared by KND was the most effective against S.
aureus, with a MIC value of 256 µg/mL.
Table 3. Mean values of the Minimum Inhibitory Concentration (µg/mL).
Sample
Gram-Positive Bacteria Gram-Negative Bacteria
S. aureus E. faecalis P. aeruginosa E. coli
EOO 512 ≥ 1024 427 512
EOO-β-CD (KND) 256 480 384 341
EOO-β-CD (SL) 384 341 384 256
EOO-HP-β-CD (KND) 469 512 512 341
EOO-HP-β-CD (SL) 384 402 512 341
Ampicillin - 32 - 48
Penicillin 0.13 - - -
Piperacillin + Tazobactam - - 2 -
Abbreviations: EOO, Euterpe oleracea oil; EOO-β-CD, EOO and β-cyclodextrin inclusion complex; EOO-HP-β-CD,
EOO and hydroxy-propyl-β-cyclodextrin inclusion complex; KND, preparation by kneading; SL, preparation
by slurry. Tests were performed in triplicate and in three repetitions. Values of p < 0.05 were considered
statistically significant.
2.5. Drug Modulating Activity
There is a growing number of studies on the discovery of new antimicrobial drugs as well as the
improvement of existing formulations [44–47]. Drug-modulating activity subsidizes a combination
therapy that does not always improve clinical outcomes but is able to decrease the chances of bacterial
resistance to multiple drugs, which is a growing problem [48].
With this aim in mind, a drug modulation assay was performed on EOO or its inclusion complexes
with antibiotics commonly prescribed in clinical practice for the treatment of nosocomial and hospital
diseases, in order to establish possible synergistic or antagonistic effects. Two antibiotics suggested by
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CLSI [49] were used against each microorganism under study, namely Ampicillin (AMP 1024 µg/mL)
or Piperacillin + Tazobactam (PIP 28.5 µg/mL + TAZ 3.5 µg/mL) against E. coli, Ciprofloxacin (CIP
4 µg/mL) or PIP + TAZ at the same dosage against P. aeruginosa, and Vancomycin (VAN 16 µg/mL) or
CIP 4 µg/mL against S. aureus and E. faecalis.
The results of modulatory activity against E. coli (Figure 7A) evidenced a decrease in the MIC
of AMP from 256 to 128 µg/mL when this antibiotic was used in combination with EOO, EOO-β-CD
prepared by either method and EOO-HP-β-CD prepared by slurry, highlighting a synergistic effect,
while EOO-HP-β-CD prepared by kneading did not influence its activity. Such a synergistic effect was
unexpected since the cell wall of Gram-negative bacteria is more complex than the one of Gram-positive
bacteria, which has a greater number of peptidoglycan layers directly linked to penicillin-binding
proteins [50,51]. Similar synergism was reported for the combination of Croton limae essential oil and
neomycin against another strain of the same bacterial species [51]. The addition of EOO to PIP + TAZ
increased the MIC from 2.0 to 4.0 µg/mL (Figure 7B), suggesting antagonistic activity, possibly related
to oil solubility. Regarding the addition of inclusion complexes to PIP + TAZ, there was no significant
variation in MIC.
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(EOO-βCD) or hydroxypropyl-β-cyclod i O-HPβCD) in combination with: ( ) Ampicillin
(AMP) and (B) Piperacillin + Tazo acta (PIP + TAZ) against E. coli; (C) Ciprofloxacin (CIP) and (D)
PIP + TAZ against P. aeruginosa; (E) Vancomycin (VAN) and (F) CIP against S. aureus, compared with
the effect of these antibiotics alone. Inclusion complexes were prepared by either kneading (K) or slurry
(S). Differences compared with the control were considered statistically significant when p < 0.05.
On the other hand, an increase in MIC of CIP from 0.25 to 2.0 µg/mL was observed when used
against P. aeruginosa (Figure 7C) in combination with EOO-HP-β-CD prepared by kneading, hence
displaying an antagonistic action. This biological response suggests a modification of physicochemical
properties of the antibiotic induced by such a large inclusion complex affecting its antibacterial
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activity [52]. On the other hand, the other preparations did not show any statistically significant
difference compared with CIP alone. Moreover, since the addition of EOO and inclusion complexes to
PIP + TAZ did not lead to any MIC variation compared to the administration of the antibiotic alone
(Figure 7D), this suggests that the above-supposed modification was antibiotic-dependent.
Although the results against S. aureus (Figure 7E) showed an increase in VAN MIC from 1.00 to
2.0 µg/mL when EOO was applied in combination, there was no statistically significant effect of the
inclusion complex in addition to the drug alone. The antimicrobial response of CIP against the same
bacterial strain was also maintained in the presence of EOO and its inclusion complexes (Figure 7F).
Since the results of modulatory activity against E. faecalis did not show any statistically significant VAN
and CIP MIC variation induced by EOO or inclusion complexes, they were not illustrated in the figure.
Taking these results together, we can conclude that, despite the EOO ability to form inclusion
complexes and improve antibacterial activity expressed as MIC, the use of cyclodextrins synergistically
improved only the modulatory effect of AMP against E. coli, thereby strengthening the conclusions of
Oliveira et al. [52]. For the other drugs, there was no significant difference in the modulatory response
when used in combination with EOO and inclusion complexes, maintaining the biological response of
the antibiotic.
3. Materials and Methods
3.1. Materials
The Euterpe oleracea Mart (açai) oil (EOO) was obtained from Amazon Oil (Belém, PA, Brazil).
This company reports that the açai fruits were collected in the Brazilian Amazon rainforest. The EOO,
obtained from the fruit pulp, was extracted through a cold pressing method without the addition of
solvents or preservatives. The selected fruits were washed and immersed in water at 45 ◦C for 60 min
and processed with the aid of a stainless-steel stripper. The açai pulp was dried at a temperature of
60 ◦C and subjected to mechanical pressing (LDS R 135/2008, 240 kg·h−1) at a temperature of 40 ◦C.
β-cyclodextrin (β-CD), hydroxypropyl-β-cyclodextrin (HP-β-CD) and resazurin were purchased from
Sigma-Aldrich (St. Louis, MO, USA) and Brain Heart Infusion (BHI) broth from Kasvi (São José dos
Pinhais, PR, Brazil). The ATCC bacterial strains were donated by the Microbiology Laboratory of the
Federal University of Campina Grande (Cajazeiras, PB, Brazil). All experiments were performed using
purified water (<1.3 µS) obtained by reverse osmosis, and the reagents were of analytical grade.
3.2. Chemical Characterization of Euterpe oleracea Mart Oil
EOO fatty acids composition was determined after their conversion into methyl esters (FAMEs)
by saponification with 0.10 M KOH in methanol and esterification with 0.12 M HCl in methanol [53].
FAMEs were detected using a gas chromatograph, model CP 3380 (Varian, Palo Alto, CA, USA),
equipped with a flame ionization detector and a CP-Sil 88 capillary column (length 60 m, internal
diameter 0.25 mm, thickness 0.25 mm (Agilent Technologies, Palo Alto, CA, USA). The operating
conditions were: Helium as a carrier gas at a flow rate of 0.9 min−1, FID detector temperature of 250 ◦C,
injector split ratio of 1:100 and temperature of 250 ◦C, injection volume of 1 µL. The temperature was
initially kept at 80 ◦C for 4 min and subsequently increased to 205 ◦C at 4 ◦C/min. Peaks of individual
FAMEs were identified by comparison of retention times with those of standard solutions. The results
were expressed as relative percentages of total fatty acids.
3.3. Preparation of Inclusion Complexes
Inclusion complexes of EOO with either β-cyclodextrin (EOO-β-CD) or hydroxypropyl-β-
cyclodextrin (EOO-HP-β-CD) were prepared by two methods, namely kneading (KND) and slurry
(SL), using the molar ratio of 1:1 (EOO:CD). The molecular weight of EOO was considered the same as
oleic acid (282.47 g·mol−1) as it was its major component, while the molecular weights of β-CD and
HP-β-CD were assumed to be 1134.98 and 1396 g·mol−1, respectively, as proposed by Pinheiro et al. [2].
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3.3.1. Kneading
The KND method was developed as described by Pinheiro et al. [2] with modifications in the
water volume and temperature utilized. Briefly, complexes were prepared by homogenizing EOO with
either cyclodextrin and adding 2.0 mL of water to form a paste. Samples were dried at 70 ◦C, crushed,
and stored in hermetically-sealed glass ampoules in a desiccator.
3.3.2. Slurry
The SL method was developed as described by Quintans-Júnior et al. [54]. Complexes were
prepared by homogenizing EOO with either cyclodextrin and then gradually adding water in a 3:4
(v/w) ratio. Samples were then agitated at 400 rpm with a magnetic stirrer for 36 h. Mixtures were kept
in a hot air circulating oven at 70 ◦C for 24 h and then conditioned in a desiccator until complete drying.
3.4. Determination of the Interaction Energy
To determine the interaction energy between oleic acid, i.e., the main EOO component, and β-CD
or HP-β-CD, two molecular models were tested using the UCSF-Chimera software (San Francisco, CA,
USA) [32], one with oleic acid entering through the wider face of cyclodextrin and the other through
its narrower face. The molecules topologies were generated by Automated Topology Builder (ATB;
version 2.2) and Repository [55].
Molecular dynamics were performed with the GROMACS program (Groningen, Netherlands) [56]
after energy minimization of the inclusion complexes, at pH 7.4 and using TIP3P as a solvent model.
Systems were maintained under isobaric (1 bar) and isothermal (300 K) conditions. The GROMOS
53A6 force field was considered for all the simulations [57]. The mean energies were obtained for a
50 ns simulation stretch. To evaluate the interaction between binder and solvent, similar simulations
of oleic acid were performed in the absence of cyclodextrin. Coulomb electrostatic interactions and
Lennard-Jones hydrophobic interactions were used as parameters to predict the free energy of the
systems according to the Linear Interaction Energy (LIE) methodology [58].
3.5. Physicochemical Characterization of Inclusion Complexes
Inclusion complexes were characterized by Fourier transform infrared (FTIR) spectroscopy using
a spectrometer, model IR Prestige-21 (Shimadzu, Kyoto, Japan), according to the Attenuated Total
Reflectance (ATR) modality. Samples were read in the wavenumber region from 4000–700 cm−1 with
20 scans and 4 cm−1 resolution.
β-CD, HP-β-CD, EOO-β-CD and EOO-HP-β-CD were then analyzed by both Scanning Electron
Microscopy (SEM) and Powder X-Ray Diffraction (PXRD). After mounting samples onto aluminum
foil supports (stubs), they were covered with carbon tape, coated with a thin layer of gold and
examined with a HITACHI® Scanning Electron Microscope model TM-3000 Tabletop (Minato-ku,
Tokio, Japan) with an accelerated voltage of 20 kV and 100×magnification. Crystalline characterization
was performed by PXRD on powdered samples using a D2 Phaser diffractometer (Bruker, Billerica,
MA, USA) equipped with a Lynxeye detector and operating with CuKα1 radiation nickel filter
(λ = 1.54 Å), 0.02◦ pitch, with measurement in the angular range of 3–45◦, and 30 kV voltage and 10 mA
current intensity.
Thermogravimetric (TG) analysis was performed on a TGA-50/50H analyzer (Shimadzu, Kyoto,
Japan) in the temperature range from 25–600 ◦C, using platinum crucibles containing approximately
3 mg of samples, under a dynamic nitrogen atmosphere (50 mL·min−1) and heating rate of 10 ◦C·min−1.
To obtain the TG/DTG profiles, the equipment was calibrated with calcium oxalate monohydrate,
according to Santos Costa et al. [59].
For the Differential Scanning Calorimetry (DSC) analysis, a sample of approximately 5–10 mg
was put into a hermetically-closed aluminum crucible and analyzed with a calorimeter, model DSC-60
(Shimadzu), under a nitrogen atmosphere at a flow rate of 50·mL−1 and a heating ratio of 10 ◦C·min−1
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in the temperature range 25–300 ◦C. Mass losses and enthalpy changes were estimated using the TA
60w program (Shimadzu) as described by Aguiar et al. [60].
3.6. Determination of Bactericidal Activity of Inclusion Complexes
The broth microdilution method was used to quantify the bactericidal activity of inclusion
complexes expressed as Minimum Inhibitory Concentration (MIC). Enterococcus faecalis (ATCC 29212)
and Staphylococcus aureus (ATCC 25932) were selected as Gram-positive standard bacterial strains,
whereas Pseudomonas aeruginosa (ATCC 27853) and Escherichia coli (ATCC 25922) as Gram-negative ones.
Strains were replicated in Brain Heart Infusion (BHI), and after 24 h the tests were performed.
Initially, each strain was diluted in saline solution at turbidity equivalent to 0.5 on the McFarlane scale.
The inoculum was added in a test tube containing 10% BHI in a 1:9 (v/v) ratio, thereby obtaining
the bacterial suspension. Microdilution was then performed in 96-well plates, in which all wells
received 100 µL of bacterial suspension. Samples (100 µL) of each substance (EOO, EOO-β-CD and
EOO-HP-β-CD) obtained either by KND or SL were applied to the first well of each plate column, as well
as control compounds, namely penicillin, ampicillin, piperacillin-tazobactam and dimethylsulfoxide
(DMSO), and a serial microdilution was carried out to the penultimate well.
The concentration of substances was 1024 µg·mL−1 in the first well and decreased to 8 µg·mL−1 in
the penultimate one, while the last well received the bacterial suspension. After incubation of plates
for 24 h at 37 ◦C, 20 µL of 0.01 (w/w) resazurin were added in each well, and turbidity was visually
assessed after 1 h at room temperature. Tests were performed in triplicate and repeated three times.
3.7. Drug Modulation Test
The Drug Modulation Test was performed according to Oliveira et al. [54] in order to evaluate
the activity of the substances under study as modulators of antimicrobial drugs commonly applied
to laboratory clinical practice [49]. For this experiment, aliquots of each sample were added to each
previously prepared bacterial suspension in order to achieve sub-inhibitory concentration (MIC/8).
For the determination of the required sample volume, the initial concentration of 1024 µg·mL−1 was
considered for a final volume of 100 µL per well. After inoculation of each well with 100 µL of bacterial
suspension, a serial microdilution was performed with 100 µL of the solution of standard antibiotic
for each strain up to the penultimate well. The final 100 µL were discarded from this microdilution.
The initial concentration of antibiotics was adopted according to the microbial susceptibility and
sensitivity provided in the CLSI manual [50]. The last well received only the bacterial suspension, and
the following procedure was the same as for MIC determination.
3.8. Statistical Analysis
The antimicrobial study was expressed as means and standard deviation, and the median was
considered for modulatory activity. The results were analyzed by two-dimensional analysis of variance
(ANOVA) using Graph Pad Prism 6.0 (San Diego, CA, USA). Values of p < 0.05 were considered
statistically significant.
4. Conclusions
This is the first study that evaluates the antibacterial and modular activity of Euterpe oleracea
oil (EOO) and cyclodextrin inclusion complexes. The results of molecular modeling, FT-IR, SEM,
PXRD, TG and DSC analyses revealed that EOO was able to successfully form inclusion complexes,
especially with β-cyclodextrin (β-CD), confirming the expectations arisen by the estimated interaction
energy between oleic acid and β-CD (∆G = −41.28 ± 0.57 kJ/mol). Accordingly, FT-IR showed
displacements in wavenumbers and a variation in peak intensity characteristic of cyclodextrin and
EOO. The morphological and crystalline characterizations showed variations in the form, appearance,
and amorphous profile of the complexes compared to cyclodextrins alone. As for thermal analysis,
temperature variations in mass losses and enthalpy variations between EOO, cyclodextrins and inclusion
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complexes confirmed the formation of inclusion complexes. Minimum Inhibitory Concentration (MIC)
results showed that the inclusion complexes presented antibacterial efficiency in Gram-positive and
negative strains, being considerably better compared to pure EOO. The MIC values of the complexes
obtained with β-CD were lower than those of EOO and complexes with hydroxypropyl-β-cyclodextrin
(HP-β-CD). Notably, β-CD inclusion complexes showed better responses regarding complexation and
biological activity than those prepared using HP-β-CD as a carrier. EOO and most of its complexes
showed a synergistic effect on ampicillin against E. coli. In addition, inclusion complexes provided
physicochemical stability to the compounds and showed no loss in EOO biological efficiency, hence
supporting its therapeutic applications. The antimicrobial response exhibited by the complexes
was of great significance because it subsidizes studies for the development of new drugs and
pharmaceutical forms.
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